AI Financial Corp. reported an improved business outlook after mitigating earlier going-concern risks tied to a $348 million loss from its WLFI token holdings. The company’s WLFI assets dropped from an initial $1.4 billion valuation to about $380 million, with shares falling 92% since the crypto deal, trading below Nasdaq's $1 minimum share price requirement. AI Financial faces potential Nasdaq delisting within two weeks if it cannot regain compliance. The company cannot currently sell its WLFI tokens due to lock-up agreements and plans to use some tokens as collateral or for loans. CEO Tony Isaac stated there are no current plans to sell the tokens.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
